As part of Angion's reduction in force, John F. Neylan, M.D., EVP, Chief Medical Officer and Head of Research, will depart Angion effective August 15, 2022. Dr. Neylan has served as Angion's Chief Medical Officer since December of 2018.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 USD | +1.22% | -6.57% | -9.00% |
2023 | Angion Biomedica Corp. Announces Resignation of Assaf Segal from Its Board of Directors | CI |
2023 | Angion Biomedia to Implement 10-for-1 Reverse Split | MT |
- Stock Market
- Equities
- ANGN Stock
- News ANGN BIOM
- Angion Biomedica Corp. Announces Resignation of John F. Neylan as Chief Medical Officer and Head of Research, Effective on August 15, 2022